The genomic response of tumor cells to hypoxia and reoxygenation. Differential activation of transcription factors AP-1 and NF-kappa B.

Hypoxia and reoxygenation are important pathophysiological conditions that occur during injury, ischemia, reperfusion and stroke. In tumors, hypoxia and oxidative stress are regarded as triggers for enhanced proliferation and metastasis. Hypoxia and reoxygenation exert part of their biological effects by inducing the expression of novel genes but very little is known about the transcription factors involved. Here, we have compared the behaviour of two redox-controlled factors, AP-1 and NF-kappa B, during hypoxia and reoxygenation. We report that the DNA-binding and transcriptional activity of transcription factor AP-1 is very strongly induced in a biphasic response when HeLa cells are exposed to reduced oxygen pressure. This induction required new AP-1 protein synthesis. Different members of the Jun/Fos family of transcription factors were found in the first and second maxima of activation. The pathogen-responsive, pre-existing transcription factor NF-kappa B was not activated under hypoxic conditions. However, a p50-p65 heterodimer of NF-kappa B was rapidly and strongly activated when HeLa cells were re-exposed to normal oxygen pressure. This explains the induction of NF-kappa B-controlled inflammatory cytokine genes during reperfusion of ischemic tissue. Our data suggest that the genomic response to hypoxia is primarily mediated by AP-1 while the inflammatory response to reoxygenation is mediated by NF-kappa B.

[1]  P. Baeuerle,et al.  Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1. , 1991, The EMBO journal.

[2]  A. Koong,et al.  Hypoxia Causes the Activation of Nuclear Factor κB through the Phosphorylation of IκBα on Tyrosine Residues , 1994 .

[3]  K. Schulze-Osthoff,et al.  Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[4]  P. O'dwyer,et al.  Involvement of NF-κB in the induction of NAD(P)H: Quinone oxidoreductase (DT-diaphorase) by hypoxia, oltipraz and mitomycin C , 1995 .

[5]  D. Faller,et al.  Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells. , 1990, The Journal of clinical investigation.

[6]  S. Antonarakis,et al.  Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[7]  S. Ogawa,et al.  Hypoxia induces glucose transporter expression in endothelial cells. , 1992, The American journal of physiology.

[8]  P. Baeuerle,et al.  A role for oxygen radicals as second messengers. , 1991, Trends in cell biology.

[9]  T S Herman,et al.  Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma. , 1990, Cancer research.

[10]  M. Karin,et al.  JunB differs from c-Jun in its DNA-binding and dimerization domains, and represses c-Jun by formation of inactive heterodimers. , 1993, Genes & development.

[11]  D. Baltimore,et al.  I kappa B: a specific inhibitor of the NF-kappa B transcription factor. , 1988, Science.

[12]  P. Baeuerle The inducible transcription activator NF-κB: regulation by distinct protein subunits , 1991 .

[13]  P. Baeuerle,et al.  H2O2 and antioxidants have opposite effects on activation of NF‐kappa B and AP‐1 in intact cells: AP‐1 as secondary antioxidant‐responsive factor. , 1993, The EMBO journal.

[14]  M. Roederer,et al.  Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[15]  T. Kwok,et al.  Hypoxia-induced drug resistance: comparison to P-glycoprotein-associated drug resistance. , 1991, British Journal of Cancer.

[16]  K. Nose,et al.  Transcriptional activation of early-response genes by hydrogen peroxide in a mouse osteoblastic cell line. , 1991, European journal of biochemistry.

[17]  I. Tannock,et al.  Response of Chinese hamster ovary cells to anticancer drugs under aerobic and hypoxic conditions. , 1981, British Journal of Cancer.

[18]  A. Boveris,et al.  Time course and mechanism of oxidative stress and tissue damage in rat liver subjected to in vivo ischemia-reperfusion. , 1993, The Journal of clinical investigation.

[19]  L. Packer,et al.  Transient Overexpression of Catalase Does Not Inhibit TNF- or PMA-Induced NF-κB Activation , 1995 .

[20]  Georg Breier,et al.  Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo , 1992, Nature.

[21]  T. Curran,et al.  Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. , 1994, Molecular and cellular biology.

[22]  D. Marmé,et al.  Hypoxia-induced transcription of the vascular endothelial growth factor gene is independent of functional AP-1 transcription factor. , 1995, Biochemical and biophysical research communications.

[23]  D. Pinsky,et al.  Hypoxia-mediated induction of endothelial cell interleukin-1 alpha. An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface. , 1992, The Journal of clinical investigation.

[24]  G. Semenza,et al.  Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. , 1993, The Journal of biological chemistry.

[25]  P. Cerutti,et al.  Oxidants stress induces the proto-oncogenes, C-fos and C-myc in mouse epidermal cells. , 1990, Bulletin du cancer.

[26]  M. Karin Signal transduction from the cell surface to the nucleus through the phosphorylation of transcription factors. , 1994, Current opinion in cell biology.

[27]  E. Goldwasser,et al.  Expression of the erythropoietin gene. , 1986, Blood cells.

[28]  R. Tjian,et al.  Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements , 1987, Cell.

[29]  H. Pahl,et al.  Phosphorylation of human I kappa B‐alpha on serines 32 and 36 controls I kappa B‐alpha proteolysis and NF‐kappa B activation in response to diverse stimuli. , 1995, The EMBO journal.

[30]  M. Koury,et al.  Anemia induces accumulation of erythropoietin mRNA in the kidney and liver. , 1986, Molecular and cellular biology.

[31]  D. Faller,et al.  Hypoxia induces lymphocyte adhesion to human mesenchymal cells via an LFA-1-dependent mechanism. , 1993, American Journal of Physiology.

[32]  M. Karin,et al.  Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor , 1987, Cell.

[33]  M. Karin,et al.  Rapid and preferential activation of the c-jun gene during the mammalian UV response , 1991, Molecular and cellular biology.

[34]  D. Männel,et al.  Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells , 1992, The Journal of experimental medicine.

[35]  P. Baeuerle,et al.  Redox Control of Gene Expression by Eukaryotic Transcription Factors NF-κB, AP-1 and SRF/TCF , 1994 .

[36]  J. Remacle,et al.  Hypoxia stimulates human endothelial cells to release smooth muscle cell mitogens: role of prostaglandins and bFGF. , 1994, Experimental cell research.

[37]  Ying Li,et al.  Regulation of human NAD(P)H:quinone oxidoreductase gene. Role of AP1 binding site contained within human antioxidant response element. , 1992, The Journal of biological chemistry.

[38]  L. Packer,et al.  Inhibition of NF-κB Activation by Vitamin E Derivatives , 1993 .

[39]  B. Teicher,et al.  The hypoxic tumor cell: a target for selective cancer chemotherapy. , 1980, Biochemical pharmacology.

[40]  D. Stoler,et al.  Anoxia-inducible endonuclease activity as a potential basis of the genomic instability of cancer cells. , 1992, Cancer research.

[41]  R. Treisman Ternary complex factors: growth factor regulated transcriptional activators. , 1994, Current opinion in genetics & development.

[42]  K. Schulze-Osthoff,et al.  転写因子NF‐κBとAP‐1の活性化に及ぼすチオレドキシンと抗酸化剤の異なった効果 , 1994 .

[43]  A. Israël,et al.  NF-κB and related proteins: Rel/dorsal homologies meet ankyrin-like repeats , 1992 .

[44]  M. Karin,et al.  The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. , 1991, Biochimica et biophysica acta.

[45]  S. Gerstberger,et al.  Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation , 1995, Science.

[46]  J. Woodgett,et al.  The stress-activated protein kinases are major c-Jun amino-terminal kinases activated by ischemia and reperfusion. , 1994, The Journal of biological chemistry.

[47]  C Y Hsu,et al.  Expression of c‐fos and c‐jun family genes after focal cerebral ischemia , 1993, Annals of neurology.

[48]  E. Keshet,et al.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.

[49]  R. Dempsey,et al.  Ischemic induction of protooncogene expression in gerbil brain. , 1991, Journal of molecular neuroscience : MN.

[50]  C. Coleman,et al.  Chemical modifiers of cancer treatment. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  P. Cerutti,et al.  Mechanism of c-fos induction by active oxygen. , 1992, Cancer research.

[52]  P. Cerutti,et al.  The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-kappa B. , 1995, Chemistry & biology.

[53]  A. Godwin,et al.  Effects of hypoxia on detoxicating enzyme activity and expression in HT29 colon adenocarcinoma cells. , 1994, Cancer research.

[54]  P. Baeuerle,et al.  Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.

[55]  R. Kurth,et al.  Inhibition of HIV‐1 replication and NF-x B activity by cysteine and cysteine derivatives , 1991, AIDS.

[56]  K. Webster,et al.  Regulation of fos and jun immediate-early genes by redox or metabolic stress in cardiac myocytes. , 1994, Circulation research.